Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,250,719 papers from all fields of science
Search
Sign In
Create Free Account
Neuromuscular Diseases
Known as:
neuromuscular disorder
, NEUROMUSCULAR DISEASE, NOS
, neuromyopathies
Expand
A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
44 relations
Abnormal involuntary movement
Cataplexy
Complex Regional Pain Syndromes
Doxapram
Expand
Narrower (26)
Benign congenital hypotonia
Cyprus facial neuromusculoskeletal syndrome
Epilepsy, Generalized
Extrapyramidal and movement disorders
Expand
Broader (2)
Myopathy
Peripheral Neuropathy
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study.
S. Antonia
,
S. Goldberg
,
+8 authors
N. Rizvi
The Lancet Oncology
2016
Corpus ID: 37825968
Highly Cited
2005
Highly Cited
2005
Synaptic Mitochondria Are Critical for Mobilization of Reserve Pool Vesicles at Drosophila Neuromuscular Junctions
P. Verstreken
,
C. Ly
,
K. Venken
,
Tong-Wey Koh
,
Yi Zhou
,
H. Bellen
Neuron
2005
Corpus ID: 11579820
Review
2004
Review
2004
Pulmonary complications of chronic neuromuscular diseases and their management
C. Perrin
,
J. Unterborn
,
C. D. Ambrosio
,
N. Hill
Muscle and Nerve
2004
Corpus ID: 24920717
Chronic neuromuscular diseases may affect all major respiratory muscles groups including inspiratory, expiratory, and bulbar, and…
Expand
Review
1996
Review
1996
The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders.
S. Collins
Gastroenterology
1996
Corpus ID: 14976785
Highly Cited
1990
Highly Cited
1990
Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere
J. Sanes
,
E. Engvall
,
R. Butkowski
,
D. D. Hunter
Journal of Cell Biology
1990
Corpus ID: 12172762
Laminin and collagen IV are components of most basal laminae (BLs). Recently, both have been shown to be products of multigene…
Expand
Highly Cited
1989
Highly Cited
1989
A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA.
E. Schon
,
Rosario Rizzuto
,
C. Moraes
,
H. Nakase
,
M. Zeviani
,
S. DiMauro
Science
1989
Corpus ID: 40749880
Kearns-Sayre syndrome (KSS) and progressive external ophthalmoplegia (PEO) are related neuromuscular disorders characterized by…
Expand
Highly Cited
1989
Highly Cited
1989
Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy.
J. Shoffner
,
M. Lott
,
A. Voljavec
,
S. Soueidan
,
D. Costigan
,
D. Wallace
Proceedings of the National Academy of Sciences…
1989
Corpus ID: 44639959
The muscle mitochondria of a patient with Kearns-Sayre/chronic external ophthalmoplegia plus syndrome were found to be completely…
Expand
Highly Cited
1987
Highly Cited
1987
Non-competitive antagonists of excitatory amino acid receptors
J. Kemp
,
A. Foster
,
E. Wong
Trends in Neurosciences
1987
Corpus ID: 53156853
Highly Cited
1973
Highly Cited
1973
TURNOVER OF TRANSMITTER AND SYNAPTIC VESICLES AT THE FROG NEUROMUSCULAR JUNCTION
B. Ceccarelli
,
W. P. Hurlbut
,
A. Mauro
Journal of Cell Biology
1973
Corpus ID: 1024041
Curarized cutaneous pectoris nerve-muscle preparations from frogs were stimulated at 10/s or at 2/s for periods ranging from 20…
Expand
Review
1973
Review
1973
Chemical transmission in invertebrate central nervous systems and neuromuscular junctions.
H. Gerschenfeld
Physiological Reviews
1973
Corpus ID: 39293489
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE